These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6504695)

  • 21. Detection of platelet-bound and serum platelet-bindable antibodies for diagnosis of idiopathic thrombocytopenic purpura in dogs.
    Lewis DC; Meyers KM; Callan MB; Bücheler J; Giger U
    J Am Vet Med Assoc; 1995 Jan; 206(1):47-52. PubMed ID: 7744662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
    Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
    Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet size in thrombocytopenia due to sepsis.
    Bessman JD; Gardner FH
    Surg Gynecol Obstet; 1983 Feb; 156(2):177-80. PubMed ID: 6681682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
    Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
    Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-dependent platelet antibodies in children: problem or merely problematic?
    Parker RI
    Pediatr Crit Care Med; 2007 Jul; 8(4):404-5. PubMed ID: 17622926
    [No Abstract]   [Full Text] [Related]  

  • 26. [The antiaggregation effect of ticlopidine on blood platelets preliminary results and prospectives for studies in various diseases].
    Andriani A; Chiappetta MG; Fabiani M; Mosiello G; Beni A
    Clin Ter; 1983 Feb; 104(3):219-22. PubMed ID: 6345050
    [No Abstract]   [Full Text] [Related]  

  • 27. [EDTA-dependent pseudothrombocytopenia: clinical aspects and laboratory tests].
    Saigo K; Sakota Y; Masuda Y
    Rinsho Byori; 2005 Jul; 53(7):646-53. PubMed ID: 16104534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist-inducible platelet activation in chronic idiopathic autoimmune thrombocytopenia.
    Panzer S; Höcker L; Rieger M; Vormittag R; Koren D; Dunkler D; Pabinger I
    Eur J Haematol; 2007 Sep; 79(3):198-204. PubMed ID: 17655706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
    Bream-Rouwenhorst HR; Hobbs RA
    Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of antiplatelet autoantibody assays in the diagnosis of immune thrombocytopenic purpura.
    McMillan R
    Curr Hematol Rep; 2005 Mar; 4(2):160-5. PubMed ID: 15720967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukopenia due to ticlopidine in a patient with chronic renal failure.
    Bedani PL; Fiocchi O; Scapoli PL; Farinelli A
    Haematologica; 1984; 69(5):641-2. PubMed ID: 6437940
    [No Abstract]   [Full Text] [Related]  

  • 32. [Side effects of ticlopidine; clinical observation and immunological study].
    de Fraiture WH; Claas FH; Meyboom RH
    Ned Tijdschr Geneeskd; 1982 Jun; 126(23):1051-4. PubMed ID: 6213869
    [No Abstract]   [Full Text] [Related]  

  • 33. [Agranulocytosis caused by ticlopidine].
    Marmont AM; Lotti G; Nati S; Martinengo M; Morgano A
    Recenti Prog Med; 1985 May; 76(5):245-8. PubMed ID: 4023387
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiaggregatory, physiological and clinical effects of ticlopidine in subjects with peripheral atherosclerosis.
    Kirstein P; Jogestrand T; Johnsson H; Olsson AG
    Atherosclerosis; 1980 Aug; 36(4):471-80. PubMed ID: 7417366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood lipid profile in healthy subjects treated with ticlopidine.
    Violi F; Alessandri C; Iuliano L; Ghiselli A; Perrone A; Balsano F
    Atherosclerosis; 1985 Dec; 58(1-3):291-4. PubMed ID: 4091884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Per- and postoperative hemorrhage during ticlopidine therapy].
    Hurault de Ligny B; Trechot P; Kessler M; Vagner JC
    Cah Anesthesiol; 1985; 33(3):257. PubMed ID: 3893646
    [No Abstract]   [Full Text] [Related]  

  • 37. Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications.
    Panak E; Maffrand JP; Picard-Fraire C; Vallée E; Blanchard J; Roncucci R
    Haemostasis; 1983; 13 Suppl 1():1-54. PubMed ID: 6642292
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cholestatic fatty liver of probably iatrogenic origin].
    Pistone AM; Podestà F; Raviolo E; Testa D; Grosso B; Toselli P; Nyffeneger G
    Recenti Prog Med; 1986 Apr; 77(4):188-90. PubMed ID: 3715186
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction in human blood platelets, viruses and antibodies. I. Platelet aggregation test with microequipment.
    Penttinen K; Myllylä G
    Ann Med Exp Biol Fenn; 1968; 46(2):188-92. PubMed ID: 5733962
    [No Abstract]   [Full Text] [Related]  

  • 40. Spin label study of the effect of ticlopidine on platelets.
    Hongo T; Setaka M; Kwan T
    Jpn J Pharmacol; 1985 Sep; 39(1):59-66. PubMed ID: 2999489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.